NCT01198067 2025-09-04Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom MacroglobulinemiaM.D. Anderson Cancer CenterPhase 1 Terminated15 enrolled 12 charts
NCT02071888 2018-07-18Study of the Glutaminase Inhibitor CB-839 in Hematological TumorsCalithera Biosciences, IncPhase 1 Completed25 enrolled
NCT01078974 2016-07-25Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's MacroglobulinemiaDana-Farber Cancer InstitutePhase 1 Terminated7 enrolled 8 charts